Nancy H. Agee
Nancy H. Agee's purchase track record
Nancy H. Agee has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/21/2026 | PGEN | $25K | pending | pending | — |
| 4/20/2026 | AUB | $25K | +9.6% | pending | — |
| 8/28/2025 | PGEN | $118K | -15.8% | -16.3% | +6.3% |
| 8/19/2025 | PGEN | $49K | +50.6% | +61.8% | +6.7% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Precigen mentioned in Zacks analyst blog. Precigen was highlighted in a Zacks analyst blog alongside other companies. The stock has risen more than 50% over the last three months, moving within its 52-week range of $2.99 to $8.98. Analysts currently have an average price target of $13.65 for the shares.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
RGCO Declares Quarterly Dividend. RGC Resources announced a quarterly cash dividend. The payout contributes to a dividend yield of about 4.36%, which is relatively high for the sector. With a trailing P/E of 15.9, the dividend may appeal to income‑focused investors. The news arrives while the stock is near its recent support level.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
HR Faces Dividend Cut Risk as REITs Face Pressure. Healthcare Realty Trust is among seven high‑yield REITs flagged for possible dividend cuts, raising concerns for income‑focused investors. The company also set a date for its third‑quarter earnings call, giving analysts a chance to assess its financial health. These developments could influence how the market views HR’s dividend sustainability and earnings outlook.
Transaction History
| AUB | ▲ Buy | Grant | 922 | $0 | 10/1/2026 | View on chart |
| PGEN | ▲ Buy | Open Market | 3,411 | $25K | 8/21/2026 | View on chart |
| AUB | ▲ Buy | Grant | 827 | $0 | 7/1/2026 | View on chart |
| AUB | ▲ Buy | Open Market | 650 | $25K | 4/20/2026 | View on chart |
| AUB | ▲ Buy | Grant | 979 | $0 | 4/1/2026 | View on chart |
| PGEN | ▲ Buy | Option Exercise | 71,839 | — | 3/13/2026 | View on chart |
| PGEN | ▲ Buy | Grant | 16,096 | $56K | 3/10/2026 | View on chart |
| RGCO | ▲ Buy | Grant | 291 | $6K | 1/2/2026 | View on chart |
| AUB | ▲ Buy | Grant | 992 | $0 | 1/2/2026 | View on chart |
| RGCO | ▲ Buy | Grant | 280 | $6K | 12/1/2025 | View on chart |
| RGCO | ▲ Buy | Grant | 298 | $6K | 11/3/2025 | View on chart |
| RGCO | ▲ Buy | Grant | 277 | $6K | 10/1/2025 | View on chart |
| AUB | ▲ Buy | Grant | 567 | $0 | 10/1/2025 | View on chart |
| PGEN | ▲ Buy | Open Market | 15,000 | $69K | 9/4/2025 | View on chart |
| RGCO | ▲ Buy | Grant | 282 | $6K | 9/2/2025 | View on chart |
| PGEN | ▲ Buy | Open Market | 10,645 | $49K | 8/28/2025 | View on chart |
| PGEN | ▲ Buy | Open Market | 15,360 | $49K | 8/19/2025 | View on chart |
| RGCO | ▲ Buy | Grant | 317 | $6K | 8/1/2025 | View on chart |
| PGEN | ▲ Buy | Option Exercise | 126,760 | — | 7/5/2025 | View on chart |
| AUB | ▲ Buy | Grant | 639 | $20K | 7/1/2025 | View on chart |
| RGCO | ▲ Buy | Grant | 273 | $6K | 7/1/2025 | View on chart |
| RGCO | ▲ Buy | Grant | 305 | $6K | 6/2/2025 | View on chart |
| RGCO | ▲ Buy | Grant | 295 | $6K | 5/1/2025 | View on chart |
| RGCO | ▲ Buy | Grant | 297 | $6K | 4/1/2025 | View on chart |
| AUB | ▲ Buy | Grant | 642 | $20K | 4/1/2025 | View on chart |
| PGEN | ▲ Buy | Grant | 32,471 | $56K | 3/13/2025 | View on chart |
| RGCO | ▲ Buy | Grant | 318 | $6K | 3/3/2025 | View on chart |
| RGCO | ▲ Buy | Grant | 303 | $6K | 2/3/2025 | View on chart |
| RGCO | ▲ Buy | Grant | 312 | $6K | 1/2/2025 | View on chart |
| AUB | ▲ Buy | Grant | 528 | $0 | 1/2/2025 | View on chart |
| RGCO | ▲ Buy | Grant | 242 | $5K | 12/2/2024 | View on chart |
| RGCO | ▲ Buy | Grant | 254 | $5K | 11/1/2024 | View on chart |
| RGCO | ▲ Buy | Grant | 243 | $5K | 10/1/2024 | View on chart |
| AUB | ▲ Buy | Grant | 431 | $0 | 10/1/2024 | View on chart |
| RGCO | ▲ Buy | Grant | 257 | $5K | 9/3/2024 | View on chart |
| RGCO | ▲ Buy | Grant | 240 | $5K | 8/1/2024 | View on chart |
| PGEN | ▲ Buy | Grant | 17,605 | $25K | 7/5/2024 | View on chart |
| RGCO | ▲ Buy | Grant | 260 | $5K | 7/1/2024 | View on chart |
| AUB | ▲ Buy | Grant | 495 | $0 | 7/1/2024 | View on chart |
| RGCO | ▲ Buy | Grant | 251 | $5K | 6/3/2024 | View on chart |
| RGCO | ▲ Buy | Grant | 247 | $5K | 5/1/2024 | View on chart |
| RGCO | ▲ Buy | Grant | 254 | $5K | 4/1/2024 | View on chart |
| AUB | ▲ Buy | Grant | 460 | $0 | 4/1/2024 | View on chart |
| AUB | ▲ Buy | Grant | 31,414 | — | 4/1/2024 | View on chart |
| RGCO | ▲ Buy | Grant | 273 | $5K | 3/1/2024 | View on chart |
| RGCO | ▲ Buy | Grant | 269 | $5K | 2/1/2024 | View on chart |
| RGCO | ▲ Buy | Grant | 256 | $5K | 1/2/2024 | View on chart |
| RGCO | ▲ Buy | Grant | 279 | $5K | 12/1/2023 | View on chart |
| RGCO | ▲ Buy | Grant | 329 | $5K | 11/1/2023 | View on chart |
| RGCO | ▲ Buy | Grant | 309 | $5K | 10/2/2023 | View on chart |
| RGCO | ▲ Buy | Grant | 288 | $5K | 9/1/2023 | View on chart |
| RGCO | ▲ Buy | Grant | 259 | $5K | 8/1/2023 | View on chart |
| RGCO | ▲ Buy | Grant | 260 | $5K | 7/3/2023 | View on chart |
| RGCO | ▲ Buy | Grant | 250 | $5K | 6/1/2023 | View on chart |
| RGCO | ▲ Buy | Grant | 269 | $5K | 5/1/2023 | View on chart |
| RGCO | ▲ Buy | Grant | 225 | $5K | 4/3/2023 | View on chart |
| RGCO | ▲ Buy | Grant | 214 | $5K | 3/1/2023 | View on chart |
| RGCO | ▲ Buy | Grant | 217 | $5K | 2/1/2023 | View on chart |
| RGCO | ▲ Buy | Grant | 232 | $5K | 1/3/2023 | View on chart |
| RGCO | ▲ Buy | Grant | 214 | $5K | 12/1/2022 | View on chart |
| RGCO | ▲ Buy | Grant | 245 | $5K | 11/1/2022 | View on chart |
| RGCO | ▲ Buy | Grant | 245 | $5K | 10/3/2022 | View on chart |
| RGCO | ▲ Buy | Grant | 243 | $5K | 9/1/2022 | View on chart |
| HR | ▲ Buy | Grant | 4,280 | $110K | 8/2/2022 | View on chart |
| RGCO | ▲ Buy | Grant | 262 | $5K | 8/1/2022 | View on chart |
| RGCO | ▲ Buy | Grant | 254 | $5K | 7/1/2022 | View on chart |
| RGCO | ▲ Buy | Grant | 248 | $5K | 6/1/2022 | View on chart |
| RGCO | ▲ Buy | Grant | 246 | $5K | 5/2/2022 | View on chart |
| RGCO | ▲ Buy | Grant | 238 | $5K | 4/1/2022 | View on chart |
| RGCO | ▲ Buy | Grant | 236 | $5K | 3/1/2022 | View on chart |
| RGCO | ▲ Buy | Grant | 264 | $6K | 2/1/2022 | View on chart |
| RGCO | ▲ Buy | Grant | 187 | $4K | 1/3/2022 | View on chart |
| RGCO | ▲ Buy | Grant | 198 | $4K | 12/1/2021 | View on chart |
| RGCO | ▲ Buy | Grant | 195 | $4K | 11/1/2021 | View on chart |
| RGCO | ▲ Buy | Grant | 192 | $4K | 10/1/2021 | View on chart |
| RGCO | ▲ Buy | Grant | 181 | $4K | 9/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
AUB Q3 Earnings Preview: Analysts Expect Growth
Atlantic Union Bankshares is set to report Q3 earnings next week, with Wall Street expecting revenue growth. Recent analyst notes suggest the stock may be undervalued after a significant price run, with one firm upgrading its rating. The company trades at a trailing P/E of 11.1 and offers a 4.06% dividend yield, sitting near its 52-week high of $43.62.
AUB Q3 Earnings Preview: Analysts Expect Growth. Atlantic Union Bankshares is set to report Q3 earnings next week, with Wall Street expecting revenue growth. Recent analyst notes suggest the stock may be undervalued after a significant price run, with one firm upgrading its rating. The company trades at a trailing P/E of 11.1 and offers a 4.06% dividend yield, sitting near its 52-week high of $43.62.